Thyroid Monitoring Following Administration of Iodine-Containing Contrast: What the New FDA Recommendations Mean for Congenital Cardiac Catheterization

Faculty and Program

	Shyam K. Sathanandam, MD, FSCAI The Science Behind Hypothyroidism and Iodinated Contrast		Arash Salavitabar, MD, FSCAI Background and Review of the Literature Behind the FDA Recommendations
	Vasum Peiris, MD FDA Recommendations and Intent		Audrey C. Marshall, MD, FSCAI Response to and Implementation of the FDA Recommendations
	Henri Justino, MD, FSCAI Panel

Learning Objectives

Upon completion of this activity, participants will be able to:

Discuss FDA recommendations behind monitoring thyroid function following administration of iodine-containing contrast
Evaluate how these recommendations may affect congenital cardiac catheterization laboratories and patients

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABP MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered